Literature DB >> 10772371

Prevalence of osteoporosis risk factors and treatment among women aged 50 years and older.

J K Kirk1, J G Spangler, F S Celestino.   

Abstract

We conducted a cross-sectional, retrospective review to evaluate screening, diagnosis, and treatment of 389 women aged 50 years or older at risk for osteoporosis in a large primary care practice. Records randomly selected from a computerized database were reviewed for drug history, age, height, weight, and osteoporosis-related diagnoses, symptoms, and risk factors. Among the 389 women, 255 (65.5%) were receiving bone-preserving treatment (247 estrogen replacement exclusively). Most (70.4%) were white, with an average age of 61 years, and an average of 3.3 risk factors for osteoporosis. Risk factors were postmenopausal status 94%, age 65 years or older 53%, hysterectomy 39%, cigarette smoking 33%, and physical inactivity 30%. By logistic regression, the only positive predictor of antiresorptive therapy was hysterectomy (adjusted odds ratio [AOR] 2.52, 95% confidence interval [CI] 1.54-4.14). Negative predictors were physical inactivity (AOR 0.44, 95% CI 0.25-0.71), rheumatoid arthritis (AOR 0.31, 95% CI 0.12-0.79), and age 65 years and older (AOR 0.54, 95% CI 0.34-0.86). Controlling for age, women with four or more risk factors were 62% less likely to be receiving antiresorptive treatment (AOR 0.38, 95% CI 0.23-0.64) than those with fewer risk factors.

Entities:  

Mesh:

Year:  2000        PMID: 10772371     DOI: 10.1592/phco.20.5.405.35051

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  4 in total

1.  Incidence and causes for failure of treatment of women with proven osteoporosis.

Authors:  Noah Zafran; Zvi Liss; Ronit Peled; Michael Sherf; Haim Reuveni
Journal:  Osteoporos Int       Date:  2005-04-02       Impact factor: 4.507

2.  Factors associated with diagnosis and treatment of osteoporosis in older adults.

Authors:  S Nayak; M S Roberts; S L Greenspan
Journal:  Osteoporos Int       Date:  2009-01-17       Impact factor: 4.507

3.  Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.

Authors:  C Asche; R Nelson; C McAdam-Marx; M Jhaveri; X Ye
Journal:  Osteoporos Int       Date:  2009-10-02       Impact factor: 4.507

4.  Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaire.

Authors:  Maria Luz Rentero; Cristina Carbonell; Marta Casillas; Milagros González Béjar; Rafael Berenguer
Journal:  Open Rheumatol J       Date:  2008-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.